Metabolic fate of midodrine. (II). Distribution and protein binding.:Distribution and Protein Binding
スポンサーリンク
概要
- 論文の詳細を見る
Tissue distribution of <SUP>14</SUP>C-midodrine and its active metabolite <SUP>14</SUP>C-DMAE was investigated after oral and intravenous administration to rats using autoradiography and scintillation counting. Serum protein binding was also examined. After oral administration of <SUP>14</SUP>C-midodrine at a dose of 3.4 μmol/kg, the radioactivity was distributed extensively throughout the body except for the central nervous system, testis and fat. High concentration of radioactivity was found in the gastrointestinal tract, liver and kidney followed by the lung, spleen, hypophysis and adrenal. The levels in these tissues were higher than that in the plasma. Elimination of radioactivity from tissues paralleled that of plasma, and no marked accumulation in any tissue was found. Although the tissue concentrations in early time after oral administration of <SUP>14</SUP>C-midodrine were higher than that in the case of <SUP>14</SUP>C-DMAE, the distribution profiles were essentially similar in each case. However, 5 min after intravenous administration of <SUP>14</SUP>C-midodrine or <SUP>14</SUP>C-DMAE, the distribution profiles were found to be different from each other. DMAE and other metabolites were found in the tissues after the administration of <SUP>14</SUP>C-midodrine and only a small amount of unchanged drug was detected. Serum protein binding of <SUP>14</SUP>C-midodrine or <SUP>14</SUP>C-DMAE in vitro was 10 ?? 20 % in rats, rabbits and dogs, and 24 ?? 31 % in human. The extent of serum protein binding of radioactive substances was about 22 % at 0.5 hr after oral administration of <SUP>14</SUP>C-midodrine to rats and was increased with time.
- 日本薬物動態学会の論文
日本薬物動態学会 | 論文
- COMPETITIVE DISPLACEMENT OF SERUM PROTEIN BINDING TO REGULATE PHARMACOKINETICS OF A CEREBRAL BLOOD FLOW RADIOPHARMACEUTICAL
- Studies on the Metabolic Fate of Felodipine. (IV). Identification of New Metabolites of Felodipine in Rat.
- Metabolic Fate of Pergolide Mesylate. (2): Absorption, Distribution, Excretion of 14C-Pergolide Mesylate in Rats after Repeated Administration.
- Studies on the Metabolic Fate of 3H-TJN-101. (III): Absorption, Distribution and Excretion after Multiple Oral Administration to Rats.
- Studies on the Pharmacokinetics of Perindopril Erbumine in Rats. (1): Plasma Level Profile, Distribution, Metabolism and Excretion after Single Oral Administration.